Raymond L. Comenzo, MD, Tufts Medical Center
Advertisement
Articles by Raymond L. Comenzo, MD, Tufts Medical Center
Advertisement
Latest Updated Articles
Rapid Readouts: Results from the Phase 3 ANDROMEDA StudyPublished: January 14th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes
4
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
5